This HTML5 document contains 135 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n11http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n13https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q70049878
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в січні 1988 scientific article published on 01 January 1988 article scientifique publié en 1988 artikull shkencor i botuar më 01 janar 1988 artículu científicu espublizáu en xineru de 1988 im Januar 1988 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel
p:P577
wds:Q70049878-0DFBB86B-25B7-4B03-8386-A2E15BA0607C
wdt:P577
1988-01-01T00:00:00Z
p:P2888
wds:Q70049878-DD1E359B-76CA-4B56-957E-A7A6224C6ED2
wdt:P2888
n13:bf00390492
p:P2860
wds:Q70049878-86D8CEED-D7E6-433C-8FB6-7FDE7F990F1E wds:Q70049878-883C10E4-8705-4D8E-B546-4D852B3DC490 wds:Q70049878-888C7031-4A27-4F45-8757-B86B0408426E wds:Q70049878-8F64F917-B4C3-43AC-B398-522F0A676063 wds:Q70049878-99520C39-DC10-4D9D-A512-4B0126B1F294 wds:Q70049878-5E2050DC-7120-49EE-8C03-5A1D5B51F0C2 wds:Q70049878-5EFC9861-822F-4E4D-928B-811C6AE55DCF wds:Q70049878-6628480B-9E34-40F8-8B66-C318B5002CB2 wds:Q70049878-68A2825F-3B25-4EF3-A0F7-0BF1F3E23DA2 wds:Q70049878-6D755A95-2B3C-499E-907B-73A050588C59 wds:Q70049878-79A82F8C-0B6C-413E-A629-12730BE402B0 wds:Q70049878-258EBD16-220B-4395-9499-42D9D50F7EA8 wds:Q70049878-29DA3FB3-2329-47E8-8F77-4410F9B6DF7F wds:Q70049878-403A0338-AD05-43D0-BA1B-368A3EBFD403 wds:Q70049878-41438D1E-9E3F-4F6A-A040-D55BEABA7B73 wds:Q70049878-44D7CE30-BC33-401A-B555-30BB1AAFB974 wds:Q70049878-45397CA4-E6D3-4539-9D86-96838018D967 wds:Q70049878-551B1B5D-A9A9-4417-B625-B4B4B6633CD1 wds:Q70049878-04E60AE2-4FEB-40CE-BC93-84CD71E21864 wds:Q70049878-0671CB39-EF94-49A9-A84F-AE6C7BDB6C19 wds:Q70049878-170F028D-DE59-4A31-AAB5-163E0A5ADFE3 wds:Q70049878-1B2BA3D4-7E72-471B-9C20-33618B69B06E wds:Q70049878-FBA65085-2E26-48F2-9714-EAF170AE5837 wds:Q70049878-FE955639-53BC-4A70-B551-C81F38526947 wds:Q70049878-D9358CA9-E157-4319-86AF-913EDE5ABAE0 wds:Q70049878-E526004D-ECF1-4696-90D2-78AFF6EBE95D wds:Q70049878-EAF35754-D1FA-4385-8D64-ED2CBEA71D19 wds:Q70049878-EDD76F95-1E03-425D-964E-8D1F26D192A4 wds:Q70049878-B4D88C94-0E79-4D98-8AD3-9EDFAB5CEAC3 wds:Q70049878-B8A5F13C-097C-4F04-B78F-6886C6701244 wds:Q70049878-D167C60F-714B-491B-A0C1-5826076102BA wds:Q70049878-D583D29D-6466-4C6B-9D4A-841CCC1D4C1F wds:Q70049878-D59048E2-E347-4383-8550-33691FF8C9CC wds:Q70049878-A4473BC9-3EF1-4731-8FC0-D4D5BCBDC781 wds:Q70049878-A58D6612-ED40-43A1-A7B0-357E7F2E294A wds:Q70049878-AFF5BA4A-6E09-4E06-BA75-D93432859AA0 wds:Q70049878-B280010E-BE05-467E-A841-224A03C2CCA5
wdt:P2860
wd:Q66950243 wd:Q40841957 wd:Q70013555 wd:Q40859477 wd:Q40845099 wd:Q70691796 wd:Q40959076 wd:Q40825088 wd:Q41562926 wd:Q39727634 wd:Q38156640 wd:Q38156635 wd:Q71341280 wd:Q39870205 wd:Q40140090 wd:Q70013559 wd:Q33480781 wd:Q39423395 wd:Q40831984 wd:Q69587579 wd:Q70277275 wd:Q69283524 wd:Q70237287 wd:Q72669493 wd:Q93635092 wd:Q68721892 wd:Q54644752 wd:Q44557742 wd:Q40816712 wd:Q39497943 wd:Q39624985 wd:Q70815428 wd:Q29620070 wd:Q93593177 wd:Q53909153 wd:Q33459316 wd:Q69881444
p:P2093
wds:Q70049878-D6A54A34-C7C7-4965-8F7B-432AF1E66EB4 wds:Q70049878-200D1481-2E5F-4AAD-A139-932CA8443758 wds:Q70049878-9CC950D0-DC72-4F95-A448-027402B486E0 wds:Q70049878-9363DD93-D214-4059-9F8D-210D7A8AC14B wds:Q70049878-AF4C6058-DD31-4A1B-B114-984CFF5BE9A7 wds:Q70049878-A7CA055F-0EBB-4576-8C35-BD295D76BFB5 wds:Q70049878-A973A4F4-8BC1-4C41-BD76-DDD8C582F860 wds:Q70049878-FCEA0B5E-D215-4EEF-8358-130CF8F96FC7 wds:Q70049878-F2AEAF63-A97D-4C45-88A0-28D1FCF49760 wds:Q70049878-F38887F6-1514-4EDB-B9A5-0B4F17EA3AFF
wdt:P2093
D Messerer J G Moormann H Rasche H Sparwasser A Gottwald W Aulitzky F Porzsolt R Hautmann K Stockamp K Schumacher
rdfs:label
Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial
skos:prefLabel
Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial
schema:name
Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial
p:P1476
wds:Q70049878-7F9F93CF-FB3C-4F55-9F2A-F41AEC92750A
wdt:P1476
Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial
p:P304
wds:Q70049878-CF2D4D07-DC50-466B-B7E8-65E016014268
wdt:P304
95-100
p:P31
wds:Q70049878-CAD34898-0E50-422B-A994-B0E74EDB44F4
wdt:P31
wd:Q13442814
p:P921
wds:Q70049878-0DD93BDC-B790-4F48-8685-761A6833EFAD
wdt:P921
wd:Q6934595
p:P698
wds:Q70049878-B1BD6D01-5B44-4B17-9B7A-A5286C595733
wdtn:P698
n10:2965154
wdt:P698
2965154
p:P1433
wds:Q70049878-6FD96633-A4DF-4BC8-9F1C-18171EB0996D
wdt:P1433
wd:Q2081599
p:P433
wds:Q70049878-6A04A4E9-C5C6-4C1A-9E25-41F3FBB95018
p:P478
wds:Q70049878-BA2F7BC1-5142-4F6C-A21C-E428AC6158B4
wdt:P433
1
wdt:P478
114
p:P356
wds:Q70049878-19A456C3-AF0F-4EAB-98FA-E6E2B5855F8D
wdtn:P356
n11:BF00390492
wdt:P356
10.1007/BF00390492